Company Short-Term Debts: Baxter Corp (BAX)

Graphic logo of Baxter International (BAX)

Baxter International maintains a stable operating leverage that ensures predictable production volumes. High patent barriers and FDA oversight protect the business, although geopolitical tensions hinder the export of life-support systems. On the GURU.Markets platform, this short-term loan capital demonstrates liability dynamics, where 0.82 indicates the level of this metric, helping to assess the issuer's real debt load.

BAX Baxter International Inc. Company Short-Term Debt (07/04/2022 - 10/29/2026)

Baxter Healthcare - analytical breakdowns and key metrics (BAX)

- price and consensus price forecast:
Stock Price Baxter|BAX - Consensus Target
- market capitalization data:
Market Capitalization Baxter International|BAX - Enterprise Value
- book capitalization data:
Net Assets per Single Share Baxter|BAX - Company Book Value|Market Cap to Net Assets Ratio baxter.com|BAX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Baxter International|BAX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Baxter International|BAX - Company Aggregate Debt|Debt to Book Capitalization Ratio Baxter International|BAX - Long-Term Debt Volume|Company Current Liabilities Baxter
Fundamental company valuation:Baxter BAX
Product sample of Baxter International

This indicator aggregates the liabilities of Baxter International (BAX) with maturities of up to one year. This metric assesses current liquidity and the company's ability to service operational debts. Geopolitical risks and sanctions complicate contract execution, placing pressure on working capital. Analyzing short-term borrowing volumes allows for an assessment of business resilience to external shocks. This chart's price action confirms the level of financial capital protection.

Competitor analysis

ISRG: Company Short-Term Debts|DHR - Company Current Liabilities|BDX: Company Short-Term Debts|STE (STERIS Group) - Company Short-Term Debts|Company Short-Term Debt West Pharmaceutical Services|Company Short-Term Debt masimo.com (MASI)|Stevanato Group (STVN) - Company Current Liabilities|Company Short-Term Loans and Borrowings Teleflex Inc. (TFX)|Company Short-Term Debts MMSI|Nobel Biocare - Short-Term Debt Volume|ICU Medical, Inc. (ICUI) - Company Short-Term Debt|XRAY: Company Short-Term Indebtedness|LeMaitre Vascular - Company Short-Term Debt|Short-Term Debt Volume AtriCure Inc|STAAR Surgical Corp (STAA) - Company Current Liabilities|Amount of Current Liabilities NAGE|ZimVie Inc. (ZIMV) - Company Short-Term Debt|Company Short-Term Loans and Borrowings angiodynamics.com ANGO|Company Current Liabilities CERS (Cerus)|Alpha Teknova - Company Short-Term Debts|MGRM: Company Short-Term Debt|STSS - Company Current Liabilities|Company Short-Term Debts INFU|UTMD (utahmed.com) - Short-Term Debt|Company Short-Term Debt KORU Medical Systems, Inc. (KRMD)|Company Short-Term Indebtedness Nyxoah SA (NYXH)|Company Current Liabilities Microbot Medical Inc|Amount of Current Liabilities PDEX (Pro-Dex Inc.)|Company Short-Term Debt ZTEK|Short-Term Debt Volume elutia.com ELUT|MLSS - Company Short-Term Debts|NXGL - Company Short-Term Debt|RVP: Company Short-Term Debts|Company Short-Term Debts Harvard Bioscience Inc.|Company Current Liabilities Femasys Inc. (FEMY)|Company Short-Term Indebtedness Meihua Medical (MHUA)|Company Current Liabilities Predictive Oncology|Amount of Current Liabilities callanjmb.com (CJMB)|ATRI: Company Short-Term Debts|NeuroMetrix Corporation - Short-Term Debt